Advertisement

Index by author

May 01, 2004; Volume 309,Issue 2

  1. Dallinger, Susanne

    1. Specific Endothelin ETA Receptor Antagonism Does Not Modulate Insulin-Induced Hemodynamic Effects in the Human Kidney, Eye, or Forearm
      Anna Rab, Susanne Dallinger, Kaija Polak, Johannes Pleiner, Elzbieta Polska, Michael Wolzt and Leopold Schmetterer
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 692-696; DOI: https://doi.org/10.1124/jpet.103.059444

  2. Delmas, Patrick

    1. Pharmacological and Signaling Properties of Endogenous P2Y1 Receptors in Cystic Fibrosis Transmembrane Conductance Regulator-Expressing Chinese Hamster Ovary Cells
      Brice Marcet, Valérie Chappe, Patrick Delmas and Bernard Verrier
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 533-539; DOI: https://doi.org/10.1124/jpet.103.063396

  3. De Nucci, Gilberto

    1. Atypical β-Adrenoceptor Subtypes Mediate Relaxations of Rabbit Corpus Cavernosum
      Cleber E. Teixeira, Juliana S. Baracat, Angelina Zanesco, Edson Antunes and Gilberto De Nucci
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 587-593; DOI: https://doi.org/10.1124/jpet.103.062026

  4. De Petrocellis, L.

    1. Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
      I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A.H.-P. Krauss, L. Shi, C. E. Protzman, C. Li, Y. Liang, A. L. Nieves, K. M. Kedzie, R. M. Burk, V. Di Marzo and D. F. Woodward
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 745-757; DOI: https://doi.org/10.1124/jpet.103.061705

  5. Dillon, Glenn H.

    1. Enantioselectivity of α-Benzyl-α-methyl-γ-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function
      Eric B. Gonzales, Cathy L. Bell-Horner, Maria Antonette M. de la Cruz, James A. Ferrendelli, Douglas F. Covey and Glenn H. Dillon
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 677-683; DOI: https://doi.org/10.1124/jpet.103.063008

  6. Di Marzo, V.

    1. Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
      I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, F. Fezza, A.H.-P. Krauss, L. Shi, C. E. Protzman, C. Li, Y. Liang, A. L. Nieves, K. M. Kedzie, R. M. Burk, V. Di Marzo and D. F. Woodward
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 745-757; DOI: https://doi.org/10.1124/jpet.103.061705

  7. Dogne, Jean-Michel

    1. Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time
      Jean-Michel Dogné, Julien Hanson, Xavier de Leval, Philippe Kolh, Vincent Tchana-Sato, Laurence de Leval, Stéphanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 498-505; DOI: https://doi.org/10.1124/jpet.103.063610

  8. Doherty, G.

    1. Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes
      M. Forrest, S.-Y. Sun, R. Hajdu, J. Bergstrom, D. Card, G. Doherty, J. Hale, C. Keohane, C. Meyers, J. Milligan, S. Mills, N. Nomura, H. Rosen, M. Rosenbach, G.-J. Shei, I. I. Singer, M. Tian, S. West, V. White, J. Xie, R. L. Proia and S. Mandala
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 758-768; DOI: https://doi.org/10.1124/jpet.103.062828

  9. Duggan, Mark E.

    1. A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain
      Julie A. O'Brien, Wei Lemaire, Marion Wittmann, Marlene A. Jacobson, Sookhee N. Ha, David D. Wisnoski, Craig W. Lindsley, Hervé J. Schaffhauser, Blake Rowe, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn and David L. Williams
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 568-577; DOI: https://doi.org/10.1124/jpet.103.061747

  10. During, Matthew J.

    1. Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration
      William A. Banks, Matthew J. During and Michael L. Niehoff
      Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 469-475; DOI: https://doi.org/10.1124/jpet.103.063222
Back to top

In this issue

Advertisement